Latest / WTR Small-Cap Spotlight
Enlivex (ENLV): CEO Details Why the Company Is Pioneering a Dual Biotech and Digital Asset Strategy
Send us Fan Mail
In this episode of WTR Small-Cap Spotlight, Oren Hershkovitz, CEO of Enlivex, joins host Tim Gerdeman, Vice Chair, Co-Founder, and CMO of Water Tower Research, along with Dr. John Roy, WTR’s Senior Equity Research Analyst. The conversation explores the evolved corporate strategy of Enlivex, a clinical-stage immunotherapy company that has pioneered a dual-pillar approach combining traditional drug development with a high-exposure digital asset treasury (DAT). Unlike companies that focus their treasuries on Bitcoin, Enlivex is the first public company to center its strategy…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.